Human BMP10 ELISA Kit (V2LY-0626-LY2614)

Go to compare Compare Online Inquiry
Tested Data
Request for COA
Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Sensitivity
0.011 ng/mL
Detection Range
0.02-4.5 ng/mL
Sample Type
Serum, Plasma, cell culture supernates
Specificity
Human
Assay Type
Sandwich
Reactivity
Human
Assay Time
1.5 h
Molecule Mass
48.0 kDa
Components
  • Pre-coated ELISA plate: 12 wells * 8 detachable strips
  • Standard solution: 0.5ml x1
  • Standard diluent: 3ml x1
  • Streptavidin-HRP: 6ml x1
  • Stop solution: 6ml x1
  • Substrate solution A: 6ml x1
  • Substrate solution B: 6ml x1
  • Wash buffer concentrate (25x): 20ml x1
  • Biotinylated antibody: 1ml x1

Formulations & Storage [For reference only, actual COA shall prevail!]

Storage
Store at 2-8°C
More Infomation

Target

Full Name
Bone Morphogenetic Protein 10
Function
Required for maintaining the proliferative activity of embryonic cardiomyocytes by preventing premature activation of the negative cell cycle regulator CDKN1C/p57KIP and maintaining the required expression levels of cardiogenic factors such as MEF2C and NKX2-5. Acts as a ligand for ACVRL1/ALK1, BMPR1A/ALK3 and BMPR1B/ALK6, leading to activation of SMAD1, SMAD5 and SMAD8 transcription factors. Inhibits endothelial cell migration and growth. May reduce cell migration and cell matrix adhesion in breast cancer cell lines.
Biological Process
Activin receptor signaling pathway Source: BHF-UCL
Adult heart development Source: BHF-UCL
Atrial cardiac muscle tissue morphogenesis Source: BHF-UCL
BMP signaling pathway Source: BHF-UCL
Cardiac muscle cell proliferation Source: UniProtKB
Cell adhesion Source: UniProtKB-KW
Heart trabecula formation Source: BHF-UCL
Kidney development Source: Ensembl
Negative regulation of cardiac muscle hypertrophy Source: BHF-UCL
Negative regulation of cell growth Source: UniProtKB
Negative regulation of cell migration Source: UniProtKB
Negative regulation of endothelial cell migration Source: BHF-UCL
Pathway-restricted SMAD protein phosphorylation Source: BHF-UCL
Positive regulation of cardiac muscle cell proliferation Source: BHF-UCL
Positive regulation of cardiac muscle hypertrophy Source: BHF-UCL
Positive regulation of cartilage development Source: Ensembl
Positive regulation of cell proliferation involved in heart morphogenesis Source: BHF-UCL
Positive regulation of gene expression Source: Ensembl
Positive regulation of pathway-restricted SMAD protein phosphorylation Source: BHF-UCL
Positive regulation of sarcomere organization Source: BHF-UCL
Positive regulation of transcription, DNA-templated Source: BHF-UCL
Regulation of cardiac muscle contraction Source: BHF-UCL
Regulation of cardiac muscle hypertrophy in response to stress Source: BHF-UCL
Sarcomere organization Source: BHF-UCL
SMAD protein signal transduction Source: GO_Central
Ventricular cardiac muscle cell development Source: BHF-UCL
Ventricular cardiac muscle tissue morphogenesis Source: BHF-UCL
Cellular Location
Secreted

Owen, N. E., Nyimanu, D., Kuc, R. E., Upton, P. D., Morrell, N. W., Alexander, G. J., ... & Davenport, A. P. (2021). Plasma levels of apelin are reduced in patients with liver fibrosis and cirrhosis but are not correlated with circulating levels of bone morphogenetic protein 9 and 10. Peptides, 136, 170440.

Hu, Y., Yu, L., Xia, F., Liang, F., Cheng, C., Huang, Y., & Xiao, L. (2021). Expression of bone morphogenetic protein 10 in cases with endometrial carcinoma and its clinical significance. Clinical and Translational Oncology, 1-6.

Hirono, K., Saito, K., Munkhsaikhan, U., Xu, F., Wang, C., Lu, L., ... & Purevjav, E. (2019). Familial left ventricular non-compaction is associated with a rare p. V407I variant in bone morphogenetic protein 10. Circulation Journal, 83(8), 1737-1746.

Jin, Y., Zheng, W., Li, L., Huang, G., Liu, Y., Jiang, H., ... & Tang, C. (2019). Loss of BMP-10 is correlated with poor survival in ovarian cancer. Pathology-Research and Practice, 215(1), 121-126.

Jumabay, M., Zhumabai, J., Mansurov, N., Niklason, K. C., Guihard, P. J., Cubberly, M. R., ... & Boström, K. I. (2018). Combined effects of bone morphogenetic protein 10 and crossveinless‐2 on cardiomyocyte differentiation in mouse adipocyte‐derived stem cells. Journal of cellular physiology, 233(3), 1812-1822.

Tillet, E., Ouarné, M., Desroches-Castan, A., Mallet, C., Subileau, M., Didier, R., ... & Bailly, S. (2018). A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides most BMP biological activity in plasma. Journal of Biological Chemistry, 293(28), 10963-10974.

Mitrofan, C. G., Appleby, S. L., Nash, G. B., Mallat, Z., Chilvers, E. R., Upton, P. D., & Morrell, N. W. (2017). Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-α-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2. Journal of Biological Chemistry, 292(33), 13714-13726.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Human BMP10 ELISA Kit?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

online inquiry
Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.